Vaccinex, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2020-12-31 was 0.00 shares.
- Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2020-09-30 was 2.76K shares.
- Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2020-06-30 was 0.00 shares.
- Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2020-03-31 was 1.02K shares.
- Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 3.78K shares.
- Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2018 was 700.00 shares, a 65.64% decline from fiscal 2017.
- Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2017 was 2.04K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 3.78K shares 10-K · filed 2022-03-31 |
| 2020-09-30 | 2.76K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | |
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | |
| 2020-03-31 | 1.02K shares 10-Q · filed 2020-05-14 | |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | 700.00 shares 10-K · filed 2020-03-09 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | |
| 2017-12-31 | 2.04K shares 10-K · filed 2019-03-13 |